Bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. Our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable diseases of the central nervous system.
Bioasis Technologies Inc. (represented by John Proffitt of Shadow Lake Group) will be meeting with potential partners at BIO Europe Spring.
- March 20–22, 2023 | Basel, Switzerland
- March 28–30, 2023 | Digital
Please log in to register or schedule time to learn more about Bioasis Technologies Inc. and our xB3 platform.